Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001493152-25-005754 0001261725 XXXXXXXX LIVE 21 Common Stock, par value $0.02 per share 08/20/2025 false 0000771999 26253C201 DSS, INC. 275 Wiregrass Pkwy, West Henrietta NY 14586 Heng Fai Ambrose Chan 011 65 6333 9181 9 Temasek Boulevard #16-04, Suntec Tower Singapore U0 038989 0001261725 N Heng Fai Ambrose Chan PF N U0 6730059.00 0.00 6730059.00 0.00 6730059.00 N 69.6 IN (1) The beneficial ownership of Heng Fai Ambrose Chan includes 6,730,059 shares of common stock, consisting of (a) 1,002,978 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Ambrose Chan; (b) 1,184,475 shares of common stock held by Heng Fai Ambrose Chan directly; (c) 311,634 shares of common stock held by Global Biomedical Pte. Ltd., a subsidiary of Alset International Limited; (d) 2,581,268 shares of common stock and debt convertible into 581,395 shares of common stock held by Alset Inc.; and (e) 1,068,309 shares of common stock held by Alset International Limited, a subsidiary of Alset Inc. (2) Based on 9,092,518 shares of the common stock of the Issuer outstanding as of August 21, 2025. 0001750106 N Alset Inc. OO N TX 4542606.00 0.00 4542606.00 0.00 4542606.00 N 47.0 CO (1) Includes 2,581,268 shares of common stock and debt convertible into 581,395 shares of common stock held directly by Alset Inc.; 311,634 shares of common stock held by Global Biomedical Pte. Ltd., a subsidiary of Alset International Limited; and 1,068,309 shares of common stock held by Alset International Limited, a subsidiary of Alset Inc. (2) Based on 9,092,518 shares of the common stock of the Issuer outstanding as of August 21, 2025. Y Global Biomedical Pte. Ltd. OO N U0 311634.00 0.00 311634.00 0.00 311634.00 N 3.4 CO Based on 9,092,518 shares of the common stock of the Issuer outstanding as of August 21, 2025. 0001660984 N Alset International Limited OO N U0 1379943.00 0.00 1379943.00 0.00 1379943.00 N 15.2 CO Based on 9,092,518 shares of the common stock of the Issuer outstanding as of August 21, 2025. Common Stock, par value $0.02 per share DSS, INC. 275 Wiregrass Pkwy, West Henrietta NY 14586 Heng Fai Ambrose Chan c/o Alset International Limited, 9 Temasek Boulevard #16-04, Suntec Tower Two, Singapore 038987 Chairman and Chief Executive Officer, Alset International Limited, 9 Temasek Boulevard #16-04, Suntec Tower Two, Singapore 038987 Singapore On August 20, 2025, the Issuer issued a convertible promissory note (the "Convertible Note") to Alset Inc. in the amount of $500,000.00. Under the terms of the Convertible Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of $0.86 per share. On August 20, 2025, the Issuer issued a convertible promissory note (the "Convertible Note") to Alset Inc. in the amount of $500,000.00. Under the terms of the Convertible Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of $0.86 per share. Heng Fai Ambrose Chan: 6,730,059, 69.6% Alset Inc.: 4,542,606, 47.0% Global Biomedical Pte. Ltd.: 311,634, 3.4% Alset International Limited: 1,379,943, 15.2% Heng Fai Ambrose Chan: 6,164,664 Alset Inc.: 4,542,606 Global Biomedical Pte. Ltd.: 311,634 Alset International Limited: 1,379,943 None. Joint Filing Agreement between Heng Fai Chan, Global Biomedical Pte. Ltd. and Alset Inc., incorporated by reference to Amendment No. 13 to the Schedule 13D filed on September 20, 2021. Heng Fai Ambrose Chan /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, an Individual 08/22/2025 Alset Inc. /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Chief Executive Officer, Alset Inc. 08/22/2025 Global Biomedical Pte. Ltd. /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Director, Global Biomedical Pte. Ltd. 08/22/2025 Alset International Limited /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Chief Executive Officer, Alset International Limited 08/22/2025